PMID: 42338042

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials.

Wharton Sean, Stefanski Adam, Chen Jiaxun, Rao Girish, Twum Elvis Asare, Denning Max

Diabetes, obesity & metabolism · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.